Skip to content

AtheroNova Inc.: 10-Q filed 2012-11-13

What AtheroNova Inc. reported in its quarterly report filed 2012-11-13 (fiscal Q3 2012): 27 published measures, 86 facts as tagged in accession 0001437749-12-011534.

This filing

Form
10-Q (quarterly report)
Filed
2012-11-13
Fiscal period
fiscal Q3 2012
Accession
0001437749-12-011534 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AtheroNova Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-09-30439,365USD
At 2011-12-31632,976USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-09-30-1,299,814USD
At 2011-12-31-6,183,865USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-09-30386,787USD
At 2011-12-31616,067USD
At 2011-09-30686,783USD
At 2010-12-31177,802USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-737,157USD92
2012-01-01 to 2012-09-30361,956USD274
2006-12-13 to 2012-09-30-11,217,555USD2119
2011-07-01 to 2011-09-30-3,944,816USD92
2011-01-01 to 2011-09-302,303,237USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-1,424,980USD274
2006-12-13 to 2012-09-30-4,341,895USD2119
2011-01-01 to 2011-09-30-875,113USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-09-301,200,000USD274
2006-12-13 to 2012-09-305,112,674USD2119
2011-01-01 to 2011-09-301,385,131USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-4,300USD274
2006-12-13 to 2012-09-30-383,992USD2119
2011-01-01 to 2011-09-30-1,037USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-09-301,299,814USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-07-01 to 2012-09-3028,935,233shares92
2012-01-01 to 2012-09-3028,663,035shares274
2011-07-01 to 2011-09-3026,503,747shares92
2011-01-01 to 2011-09-3024,729,573shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-07-01 to 2012-09-3028,935,233shares92
2012-01-01 to 2012-09-3031,331,702shares274
2011-07-01 to 2011-09-3026,503,747shares92
2011-01-01 to 2011-09-3027,665,915shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-0.03USD/shares92
2012-01-01 to 2012-09-300.01USD/shares274
2011-07-01 to 2011-09-30-0.15USD/shares92
2011-01-01 to 2011-09-300.09USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-0.03USD/shares92
2012-01-01 to 2012-09-300.01USD/shares274
2011-07-01 to 2011-09-30-0.15USD/shares92
2011-01-01 to 2011-09-300.08USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-01-01 to 2012-09-301,365USD274
2006-12-13 to 2012-09-308,764USD2119
2011-01-01 to 2011-09-304,840USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-09-306,155USD
At 2011-12-314,000USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-09-30819,845USD274
2006-12-13 to 2012-09-302,850,831USD2119
2011-01-01 to 2011-09-30791,111USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-09-30409,433USD
At 2011-12-31628,976USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-09-301,021,092USD
At 2011-12-316,421,186USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-07-01 to 2012-09-30658,999USD92
2012-01-01 to 2012-09-302,310,594USD274
2006-12-13 to 2012-09-307,837,899USD2119
2011-07-01 to 2011-09-30885,348USD92
2011-01-01 to 2011-09-301,842,979USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2012-07-01 to 2012-09-30474,131USD92
2012-01-01 to 2012-09-301,750,155USD274
2006-12-13 to 2012-09-305,831,517USD2119
2011-07-01 to 2011-09-30797,078USD92
2011-01-01 to 2011-09-301,571,334USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-07-01 to 2012-09-30184,868USD92
2012-01-01 to 2012-09-30560,439USD274
2006-12-13 to 2012-09-301,433,514USD2119
2011-07-01 to 2011-09-3088,270USD92
2011-01-01 to 2011-09-30271,645USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-09-3029,345,056shares
At 2011-12-3128,390,260shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-09-309,914,818USD
At 2011-12-315,392,818USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2012-09-30-1,299,814USD
At 2011-12-31-6,183,865USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2012-01-01 to 2012-09-30361,956USD274
2006-12-13 to 2012-09-30-11,217,555USD2119
2011-01-01 to 2011-09-302,303,237USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-09-302,145USD274
2006-12-13 to 2012-09-306,251USD2119
2011-01-01 to 2011-09-301,882USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-07-01 to 2012-09-30134USD92
2012-01-01 to 2012-09-30509USD274
2006-12-13 to 2012-09-304,059USD2119
2011-07-01 to 2011-09-3036USD92
2011-01-01 to 2011-09-30165USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2006-12-13 to 2012-09-302,517,668USD2119
2011-12-01 to 2011-12-31150,000USD31
2011-01-01 to 2011-09-301,385,131USD273

Inspect the source

Entity
AtheroNova Inc. / CIK 0001377053
Captured
SEC response SHA-256
81a2759e3e00d9aae8e00b49a90638e395efe58cc80cb4656b5ea1994670c236

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001377053.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))